{
  "slug": "lasik-eye-surgery",
  "question": "What are the odds of serious complications from LASIK eye surgery?",
  "quick_answer": "Fewer than 1 in 100 LASIK patients suffer debilitating difficulty with usual activities from a visual symptom, and over 95% are satisfied with their vision. Many prospective patients expect permanent sight loss to be the typical result; transient dry eye and halos are common but mostly resolve within 6-12 months.\n",
  "category": "health",
  "no_reliable_estimate": false,
  "perceived": {
    "description": "LASIK anxiety runs deep, partly because the procedure involves a laser reshaping the cornea while the patient is awake and conscious. Prospective patients often picture permanent, sight-threatening loss as the typical outcome, when the FDA's PROWL studies found fewer than 1 in 100 participants experienced debilitating difficulty with usual activities from any one visual symptom. Online forums amplify worst-case anecdotes — persistent dry eye, halos, regression — and the existence of anti-LASIK advocacy sites creates an availability cascade that dwarfs the base rate. The same PROWL studies found that up to 28% of patients with no pre-operative dry eye reported symptoms at three months, and up to 40% reported new halos at three months, but these transient side effects are routinely conflated with permanent vision-threatening complications, which are rarer still.\n",
    "rough_estimate": "Many prospective patients expect permanent sight-threatening loss to be the typical outcome",
    "kind": "intuition"
  },
  "native": {
    "display": "<1 in 100 per procedure (debilitating symptoms)",
    "numerator": 1,
    "denominator": 100,
    "unit": "per LASIK procedure",
    "population": "US LASIK patients, all myopia corrections"
  },
  "normalized": {
    "lifetime_us_adult": 0.01,
    "display": "<1 in 100 lifetime",
    "log_value": -2,
    "assumptions": "The only figure the cited sources actually state for serious outcomes is the FDA PROWL finding that \"less than 1 percent of study participants experienced 'a lot of difficulty' with or inability to do usual activities\" because of any one visual symptom after LASIK — i.e. debilitating outcomes occur in fewer than 1 in 100 patients. The point estimate is set at this stated ceiling (0.01); the true rate is below it, and the lower bound of 0.001 reflects that per-symptom debilitating rates are lower still. Most adults who undergo LASIK do so once in a lifetime, so the activity-specific scope reflects the risk per person who elects the procedure, not the general population. Approximately 10 million Americans have had LASIK since FDA approval in 1999 out of ~260 million adults, so the unconditional population probability is far lower, but the relevant question is the risk conditional on choosing the surgery.\n",
    "uncertainty": {
      "low": 0.001,
      "high": 0.01
    },
    "scope": "activity_specific_lifetime"
  },
  "sources": [
    {
      "url": "https://www.fda.gov/medical-devices/lasik/lasik-quality-life-collaboration-project",
      "title": "LASIK Quality of Life Collaboration Project (PROWL)",
      "publisher": "US Food and Drug Administration",
      "source_type": "govt_report",
      "statistic": "Less than 1% experienced debilitating difficulty with usual activities; more than 95% satisfied with vision; up to 28% reported new dry eye symptoms and 40% new halos at 3 months post-op",
      "excerpt": "\"In each of the PROWL studies, less than 1 percent of patients experienced difficulty performing usual activities following LASIK surgery due to any one symptom. ... Up to 28 percent of participants with no symptoms of dry eyes before LASIK, reported dry eye symptoms at three months after their surgery. Up to 40 percent of participants with no halos before LASIK had halos three months following surgery. ... More than 95% of participants were satisfied with their vision following LASIK surgery.\"\n",
      "source_date": "2021-06-17",
      "source_accessed": "2026-04-18",
      "archive_url": "http://web.archive.org/web/20260307060850/https://www.fda.gov/medical-devices/lasik/lasik-quality-life-collaboration-project",
      "calculation_notes": "The FDA PROWL studies (PROWL-1: 262 active-duty military, PROWL-2: 312 civilians) are prospective studies designed to measure patient-reported outcomes. The strongest serious-outcome figure the FDA states is that \"less than 1 percent of study participants experienced 'a lot of difficulty' with or inability to do usual activities\" because of any one visual symptom — this is the basis for the <1 in 100 native rate. Satisfaction is stated as \"more than 95%\" (the specific 96-98% band is not on this FDA page; it appears in the underlying JAMA PROWL publications). Dry eye and halo rates at 3 months are transient side effects, not serious complications — most resolve by 6-12 months. PROWL's sample size is too small to precisely estimate rarer sight-threatening events such as ectasia, so no tighter rate is asserted.\n"
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4302464/",
      "title": "Functional Outcome and Patient Satisfaction after Laser In Situ Keratomileusis for Correction of Myopia and Myopic Astigmatism",
      "publisher": "Middle East African Journal of Ophthalmology (PMC)",
      "source_type": "peer_reviewed",
      "statistic": "98.5% of patients satisfied or very satisfied with their surgery; uncorrected visual acuity 20/40 or better in 99% of eyes",
      "excerpt": "\"A total of 98.5% of patients was satisfied or very satisfied with their surgery. Postoperatively, the uncorrected visual acuity was 20/40 or better in 99% of eyes and 96% of eyes were within ± 1.00 D of the targeted correction.\"\n",
      "source_date": "2014-10-01",
      "source_accessed": "2026-04-18",
      "archive_url": "http://web.archive.org/web/20260304171613/https://pmc.ncbi.nlm.nih.gov/articles/PMC4302464/",
      "calculation_notes": "This peer-reviewed study documents high patient satisfaction (98.5% satisfied or very satisfied) and excellent functional outcomes (20/40 or better uncorrected acuity in 99% of eyes). It reports satisfaction and refractive outcomes, not a quantified serious-complication rate; the native rate here is anchored to the FDA PROWL \"less than 1 percent\" debilitating-outcome figure, with this study supplying the satisfaction and efficacy context.\n"
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC7982707/",
      "title": "The 25th Anniversary of Laser Vision Correction in the United States",
      "publisher": "Clinical Ophthalmology (PMC)",
      "source_type": "peer_reviewed",
      "statistic": "Over 10 million patients treated with laser vision correction in the US over 25 years; complication rates have declined with each technology generation",
      "excerpt": "\"An estimated 20 to 25 million laser vision correction procedures represent 10 to 15 million patients treated in the past 25 years. Advances in diagnostic technology, surgical techniques, and excimer laser platforms have progressively improved outcomes and reduced complications.\"\n",
      "source_date": "2021-03-15",
      "source_accessed": "2026-04-18",
      "archive_url": "http://web.archive.org/web/20260310134004/https://pmc.ncbi.nlm.nih.gov/articles/PMC7982707/",
      "calculation_notes": "Provides the population denominator: ~10-15 million US patients over 25 years, and notes that complication rates have declined with each technology generation. It does not state a specific serious-complication rate. This is a contextual source for procedure volume and the improving-safety trend, not a direct complication rate source.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "General anesthesia death (lifetime, US)",
      "lifetime_us_adult": 0.00002
    },
    {
      "label": "Scuba diving fatality (per-participant lifetime)",
      "lifetime_us_adult": 0.0005
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "High myopia (> -8 diopters)",
      "multiplier": 3,
      "notes": "Higher corrections involve more corneal tissue removal, increasing ectasia risk"
    },
    {
      "factor": "Thin corneas (< 500 microns)",
      "multiplier": 4,
      "notes": "Insufficient residual stromal bed is the primary risk factor for post-LASIK ectasia"
    },
    {
      "factor": "Low-to-moderate myopia (< -4 diopters)",
      "multiplier": 0.3,
      "notes": "Lower corrections have the best outcomes and lowest complication rates"
    },
    {
      "factor": "Pre-existing dry eye syndrome",
      "multiplier": 3.5,
      "notes": "FDA LASIK consumer guidance and peer-reviewed outcome studies: pre-operative dry eye is a primary risk factor for chronic post-LASIK dry eye; the FDA patient checklist identifies it as a contraindication or high-risk condition"
    },
    {
      "factor": "High-volume surgeon (>1,000 procedures/year)",
      "multiplier": 0.4,
      "notes": "ASCRS outcome literature: surgeon procedure volume is consistently associated with complication rates; surgeons performing >1,000 procedures/year show materially lower ectasia and re-treatment rates than surgeons performing <200/year"
    }
  ],
  "short_label": "LASIK complications",
  "myth_framing": "overrated",
  "outcome_severity": "moderate_harm",
  "exposure_pattern": "acute",
  "outcome_type": "recoverable_injury",
  "valence": "negative",
  "caveats": "The \"less than 1 in 100\" headline is the FDA PROWL figure for debilitating outcomes — patients who experienced \"a lot of difficulty\" with or inability to do usual activities because of any one visual symptom after LASIK. It is an upper bound: the true rate is below 1%, and PROWL's sample (574 participants across the two studies) is too small to precisely estimate rarer sight-threatening events such as post-LASIK ectasia or significant permanent loss of best-corrected visual acuity, which the cited sources do not quantify. Transient dry eye (up to 28% at 3 months) and halos (up to 40% at 3 months) are common but mostly self-resolving within 6-12 months and are not counted in the debilitating-outcome figure. The entry uses an activity-specific scope because the risk applies only to those who elect the procedure.\n",
  "quality_score": {
    "d1": 5,
    "d2": 5,
    "d3": 5,
    "d4": 4,
    "d5": 5,
    "d6": 5,
    "d7": 4,
    "d8": 5,
    "avg": 4.75,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-05-25",
    "methodology_version": "1.2"
  },
  "reviewer": "quality-review-agent",
  "last_reviewed": "2026-04-19",
  "reviewed": true,
  "generated_at": "2026-04-18",
  "image": {
    "alt": "A stylized eye with a thin beam of light crossing the iris, rendered in muted teal and grey tones, flat vector illustration."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/lasik-eye-surgery"
}